Displaying 1081 - 1100 of 1572
Simon Property Group, Inc., In the Matter of
Under the terms of the settlement, Simon Property Group, Inc. is required to divest property and modify tenant leases to preserve outlet center competition in parts of southwest Ohio, Chicago, Illinois, and Orlando, Florida, in the wake of Simon’s purchase of Prime Outlets Acquisition Company, LLC. In addition, Simon has agreed to remove radius restrictions for tenants with stores in its outlet malls serving the Chicago and Orlando markets.
FTC Seeks Public Comment on ConocoPhillips' Application to Modify Final Commission Order and to Approve Amended Licensing Agreements with Holly Corp.
FTC Denies Dow Chemical's Application to Modify its 2009 Consent Order Requiring Sale of Chemicals Facility in California
Hikma Pharmaceuticals PLC, In the Matter of (Baxter)
The Commission required Hikma Pharmaceuticals PLC (Hikma) to divest two generic injectable pharmaceuticals – phenytoin and promethazine – as part of a settlement allowing it to acquire certain assets from Baxter Healthcare Corporation, Inc. (Baxter). Hikma proposes to acquire Baxter’s entire generic injectable pharmaceutical business for $111.5 million, including Baxter’s Cherry Hill, New Jersey, manufacturing facility and a warehouse and distribution center in Memphis, Tennessee. Phenytoin is an anti-convulsant drug used to control and prevent seizures during or after surgery and Promethazine is used to prevent some types of allergies or allergic reactions, to prevent or control motion sickness, nausea, vomiting, and dizziness, and to help patients go to sleep and control their pain or anxiety before or after surgery.
FTC Approves Universal Health Services' and Psychiatric Solutions' Application to Sell the Delaware Behavioral Health Assets
FTC Approves Final Order Settling Charges that Hikma Pharmaceuticals PLC's Acquisition of Baxter Healthcare Assets was Anticompetitive
FTC Staff Submits Comment to FERC on Assessing the Effects of Proposed Horizontal Mergers on Market Power
FTC Seeks Public Comment on Universal Health Services' Application to Sell Las Vegas Psychiatric Facilities
FTC Staff Comment Before the Federal Energy Regulatory Commission Concerning Analysis of Horizontal Market Power under the Federal Power Act (Docket No. RM11-14-000)
FTC Challenges Grifols/Talecris Merger as Anticompetitive
FTC Conditions Irving Oil's Proposed Acquisition of ExxonMobil Assets in Maine
Dow Chemical Company, The, and Union Carbide Corporation
Dow settled antitrust concerns relating to its proposed merger with Union Carbide Corporation. Dow agreed to divest and license intellectual property necessary to the production of linear low-density polyethylene -an ingredient used in premium plastic products such as trash bags and sealable food pouches -to BP Amoco plc.
FTC Requires Hikma to Sell Two Drugs as Condition of Baxter Healthcare Acquisition
Laboratory Corporation of America and Laboratory Corporation of America Holdings, In the Matter of
The FTC challenged Laboratory Corporation of America’s $57.5 million acquisition of rival clinical laboratory testing company Westcliff Medical Laboratories, Inc., alleging that the transaction would lead to higher prices and lower quality in the Southern California market for the sale of clinical laboratory testing services to physician groups. The complaint also alleges that LabCorp’s acquisition of Westcliff would leave only two significant laboratories in Southern California competing to provide critical testing services to most physician groups.The FTC also filed an action in federal court to prevent LabCorp from integrating the Westcliff assets while the case is being tried in the administrative court. The federal court denied the FTC motion for an injunction pending appeal. Staff filed an emergency motion for an injunction pending appeal with the 9th Circuit, which denied the Commission's appeal. The Commission dismissed its complaint and closed the investigation.
FTC and Georgia Attorney General Challenge Phoebe Putney Health System's Proposed Acquisition of Palmyra Park Hospital as Anticompetitive
FTC Bureau of Competition Director Issues Statement on Providence Health & Services' Abandonment of its Plan to Acquire Spokane Cardiology and Heart Clinics Northwest
ProMedica Health System, Inc., FTC and State of Ohio v.
Laboratory Corporation of America and Laboratory Corporation of America Holdings
FTC Approves Monitor Trustee and Agreement to Ensure Polypore's Compliance with the Commission's Final Order
Displaying 1081 - 1100 of 1572